Zobrazeno 1 - 3
of 3
pro vyhledávání: '"J. C. La Rochelle"'
Autor:
N. G. Cowan, Y. Chen, T. M. Downs, B. H. Bochner, A. B. Apolo, M. P. Porter, J. C. La Rochelle, C. L. Amling, T. M. Koppie
Publikováno v:
Advances in Urology, Vol 2014 (2014)
Objectives. Level 1 evidence supports the use of neoadjuvant chemotherapy (NAC) to improve overall survival in muscle invasive bladder cancer; however utilization rates remain low. The aims of our study were to determine factors associated with NAC u
Externí odkaz:
https://doaj.org/article/9bbb395e66ec45e39fd5125400c39962
Autor:
Bernard H. Bochner, Theresa M. Koppie, Yiyi Chen, Tracy M. Downs, Andrea B. Apolo, Michael P. Porter, Nick G. Cowan, J. C. La Rochelle, Christopher L. Amling
Publikováno v:
Advances in Urology
Advances in Urology, Vol 2014 (2014)
Advances in Urology, Vol 2014 (2014)
Objectives. Level 1 evidence supports the use of neoadjuvant chemotherapy (NAC) to improve overall survival in muscle invasive bladder cancer; however utilization rates remain low. The aims of our study were to determine factors associated with NAC u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aee22d81a97337bdcce4a3314c3a443
Autor:
J. C. La Rochelle, Fairooz F. Kabbinavar, Arie S. Belldegrun, Stephen B. Riggs, Brian Shuch, Allan J. Pantuck, Tobias Klatte
Publikováno v:
Journal of Clinical Oncology. 26:5097-5097
5097 Background: Patients with renal cell carcinoma brain metastasis (RCCBM) are frequently excluded from clinical trials. NCCN guidelines do not give clear recommendations regarding central nervous system (CNS) surveillance or therapy. We set out to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::062d182a7e0dca6d2b0eba92e4eae7a4
https://doi.org/10.1200/jco.2008.26.15_suppl.5097
https://doi.org/10.1200/jco.2008.26.15_suppl.5097